Inferior Vena Cava Filters Market Size and Growth Rate:

“The Global Inferior Vena Cava Filters Market is expected to reach US$ 1,208.5 Mn by 2025 owing to growth in R&D for the development of newer treatments”

Inferior Vena Cava Filters Market Growth Drivers and Restraints:

The global inferior vena cava filters market is expected to reach US$ 1,208.5 Mn by 2025. Inferior vena cava (IVC) filters are the devices that are implanted in the largest vein of the human body which is vena cava. IVC carries the deoxygenated blood from the lower and middle body into the right atrium of the heart. This device is used to prevent life-threatening pulmonary embolism. The global inferior vena cava filters market is driven by the rising incidences of pulmonary embolism, life style changes, high cholesterol and fatty food intake, and lack of exercises. Moreover, growth in the incidence of various cardiac ailments, improvement in the research activities, increasing government funding and support, growth in the technological advancements coupled with enhanced medical imaging techniques are predicted to drive the growth of inferior vena cava filters market over the coming years. Nevertheless, high cost of the products, side effects associated with the device, stiff regulatory approvals from FDA, and device failure are obstructing the growth of global inferior vena cava filters market.

Browse More Insights of the report @ https://www.precisionbusinessinsights.com/market-reports/global-inferior-vena-cava-filters-market/

Permanent IVC Filter Dominate the Global Inferior Vena Cava Filters Market

Based on the product type, global inferior vena cava filters market is segmented into permanent IVC filter, retrievable IVC filter, and others. Retrievable IVC filter dominated the global inferior vena cava filters market owing its fewer side effects when compared to permanent IVC filters. It can be removed when the patients issue is resolved.

North America Leads the Global Inferior Vena Cava Filters Market

PBI’s global inferior vena cava filters market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America dominated the global inferior vena cava filters market through 2014-2018 and expected to dominate over 2019-2025 owing to increasing geriatric population, up surging demand for advanced and minimally invasive treatment procedure. Increasing incidences of thromboembolism is also aiding in the market growth of inferior vena cava filters in North American region. For instance, according to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually. Europe inferior vena cava filters market estimated for a momentous share in global inferior vena cava filters market owing to rise in healthcare expenditure, and growing awareness about the IVC filters. Moreover, development in healthcare infrastructure, and increase in disposable income in countries such as UK, Germany etc. are also streaming the market growth in Europe region. Asia-Pacific is a crucial region for inferior vena cava filters market due to rise in the adoption of IVC filters, escalation in the government outlay and healthcare infrastructure. Conversely, the high cost of the IVC filters, absence of skilled professionals, and little awareness regarding inferior vena cava filter are the key factors which are hindering the inferior vena cava filters market growth in Middle East and Africa region.
Launch of newer devices, and strategic alliances are the key strategies adopted by market players

Global inferior vena cava filters market further reveals that the key player’s increasingly adopting strategies such as launch of newer products, technological advancements, frequent product approvals, mergers and collaborations and long term alliance to improve market revenue share and gaining significant geographic presence across the region.

 For instance, in 2017, the FDA granted 510(k) clearance to BTG’s EKOS Control Unit 4.0. The EKOS system includes an ultrasonic device that uses acoustic pulses to quickly and safely dissolve blood clots and restore blood flow in patients with PE, deep vein thrombosis and peripheral arterial occlusions.
 Additionally, in September 2018, BTG planned to launch Sentry in the U.S. in the second half of economic year 2018-2019 and will sell the device through its existing vascular sales force. This acquisition further enhances BTG’s strength in the vascular space.
Key player’s profiles in the report are Accellent, Inc. (USA), Biosensors International Group, Ltd. (Singapore), Fukuda Denshi Co., Ltd. (Japan), Baxter International, Inc. (USA). Boston Scientific Corporation (USA), Cardinal Health, Inc. (USA), BTG plc (UK), Argon Medical Devices (USA), Abbott Laboratories (USA), B. Braun Melsungen AG (Germany), Medtronic plc (Ireland), and Volcano Corporation (USA).
Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=16750

Detailed Segmentation of Inferior Vena Cava Filters Market:

By Product Type
• Permanent IVC filter
• Retrievable IVC filter
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers
• Others

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights